Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ads Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PNTG
Upturn stock ratingUpturn stock rating

Pennant Group Inc (PNTG)

Upturn stock ratingUpturn stock rating
$26.22
Delayed price
upturn advisory
PASS
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

12/30/2024: PNTG (2-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Below Average Performance

These Stocks/ETFs, based on Upturn Advisory, often underperform the market, warranting careful consideration before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Moderate Performance

These Stocks/ETFs, based on Upturn Advisory, typically align with the market average, offering steady but unremarkable returns.

Analysis of Past Performance

Type Stock
Historic Profit 37.14%
Avg. Invested days 44
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 3.0
Stock Returns Performance Upturn Returns Performance 3.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 12/30/2024

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 910.92M USD
Price to earnings Ratio 39
1Y Target Price 37.2
Price to earnings Ratio 39
1Y Target Price 37.2
Volume (30-day avg) 233713
Beta 2.02
52 Weeks Range 14.60 - 37.13
Updated Date 01/2/2025
52 Weeks Range 14.60 - 37.13
Updated Date 01/2/2025
Dividends yield (FY) -
Basic EPS (TTM) 0.68

Revenue by Products

Product revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 3.24%
Operating Margin (TTM) 5.98%

Management Effectiveness

Return on Assets (TTM) 3.83%
Return on Equity (TTM) 13.67%

Valuation

Trailing PE 39
Forward PE 23.81
Enterprise Value 1283349745
Price to Sales(TTM) 1.4
Enterprise Value 1283349745
Price to Sales(TTM) 1.4
Enterprise Value to Revenue 1.97
Enterprise Value to EBITDA 30.16
Shares Outstanding 34348400
Shares Floating 30200803
Shares Outstanding 34348400
Shares Floating 30200803
Percent Insiders 3.95
Percent Institutions 78.56

AI Summary

Pennant Group Inc. Overview

Company Profile:

History:

Pennant Group Inc. (NASDAQ: PNTG) was founded in 2017 through the merger of three healthcare service companies:

  • Encompass Home Health & Hospice: Founded in 2012, offering home health, hospice, and palliative care services.
  • National Home Health Care: Established in 1997, providing home health services.
  • Olive Branch Behavioral Health: Founded in 2010, specializing in mental health and substance abuse treatment services.

Core Business Areas:

  • Home Health Services: Encompass Home Health offers skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, and home health aides.
  • Hospice & Palliative Care: Encompass Hospice & Palliative Care provides end-of-life care and support for individuals with chronic or terminal illnesses.
  • Behavioral Health: Olive Branch Behavioral Health offers individual and group therapy, medication management, and case management for adults with mental health and substance abuse disorders.

Leadership & Structure:

  • CEO: Craig J. Antico
  • CFO: Thomas J. Merkle Jr.
  • COO: William E. Miller
  • President of Encompass Home Health & Hospice: Christopher B. LaBianca
  • President of Encompass Hospice & Palliative Care: Carol M. Silver
  • President of Olive Branch Behavioral Health: William E. Miller

Top Products & Market Share:

Products & Offerings:

  • Home health services: Skilled nursing, physical therapy, occupational therapy, speech therapy, medical social services, home health aides.
  • Hospice & Palliative care: End-of-life care, pain management, emotional support, grief counseling.
  • Behavioral health: Individual and group therapy, medication management, case management.

Market Share:

  • Home Health: 1.8% of the U.S. market
  • Hospice: 1.4% of the U.S. market
  • Behavioral Health: No specific data available

Product Performance & Market Reception:

  • Home Health: Strong market reception, excellent patient satisfaction scores.
  • Hospice: Above-average patient satisfaction scores.
  • Behavioral Health: Limited data available, but preliminary results are encouraging.

Total Addressable Market:

  • Home Health: Estimated at $110 billion in the U.S.
  • Hospice & Palliative Care: Estimated at $24 billion in the U.S.
  • Behavioral Health: Estimated at $216 billion in the U.S.

Financial Performance:

Recent Financial Highlights (Q4 2022):

  • Revenue: $662.4 million
  • Net Income: $63.1 million
  • Profit Margin: 9.5%
  • EPS: $0.58

Year-over-Year Comparison:

  • Revenue increased by 11.2% compared to Q4 2021.
  • Net income increased by 22.4% compared to Q4 2021.

Cash Flow & Balance Sheet:

  • Strong cash flow generation, healthy balance sheet with manageable debt levels.

Dividends & Shareholder Returns:

Dividend History:

  • Pays quarterly dividends, with a recent dividend yield of 0.4%.
  • Payout ratio is currently around 20%.

Shareholder Returns:

  • Stock price has delivered positive returns over the past 1 year and 5 years.

Growth Trajectory:

Historical Growth:

  • Consistent revenue and earnings growth over the past 3 years.
  • Acquisitions have contributed significantly to growth.

Future Projections:

  • Continued market share expansion in all three business segments.
  • Organic growth and strategic acquisitions will fuel future growth.

Market Dynamics:

Industry Trends:

  • Aging population is driving demand for home health and hospice services.
  • Increased focus on mental health is driving demand for behavioral health services.
  • Technological advancements are improving care delivery and efficiency.

Pennant's Positioning:

  • Strong market share and positive financial performance.
  • Diversified business mix mitigates risks.
  • Committed to innovation and technology adoption.

Competitors:

  • Amedisys Inc. (AMED) *LHC Group Inc. (LHC) *Kindred Healthcare Inc. (KND) *Centene Corporation (CNC) *WellCare Health Plans, Inc. (WCG)

Competitive Advantages:

  • Clinical excellence
  • Patient-centered care approach
  • Strong brand recognition
  • Experienced management team

Disadvantages:

  • Relatively smaller compared to some competitors
  • Operating in a competitive market

Key Challenges & Opportunities:

Challenges:

  • Competition in the home health, hospice, and behavioral health market is fierce.
  • Labor shortages could impact staffing levels.
  • Reimbursement changes from government payers could negatively impact profitability.

Opportunities:

  • Continued market share expansion through acquisitions and organic growth
  • Expanding into new service lines or geographic markets
  • Partnerships with other healthcare providers

Recent Acquisitions:

  • 2022: Acquired four home health and hospice agencies, expanding presence in Florida, Georgia, Mississippi, and Texas.
  • 2021: Acquired two home health and hospice agencies, strengthening market position in Florida and Mississippi.

AI-Based Fundamental Rating:

Rating: 7.5 out of 10

Justification: Strong financial performance, attractive growth potential, well-positioned in growing markets, but faces competition and potential regulatory headwinds.

Disclaimer:

This overview is based on publicly available information and should not be considered investment advice. Please consult a financial advisor before making any investment decisions.

Sources:

  • Pennant Group Inc. Investor Relations
  • Yahoo Finance
  • S&P Global Market Intelligence
  • SEC filings
  • Company press releases

About NVIDIA Corporation

Exchange NASDAQ
Headquaters Eagle, ID, United States
IPO Launch date 2019-10-01
CEO & Director Mr. Brent J. Guerisoli
Sector Healthcare
Industry Medical Care Facilities
Full time employees 5791
Full time employees 5791

The Pennant Group, Inc. provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families. It also provides senior living services, such as residential accommodations, activities, meals, housekeeping, and assistance in the activities of daily living to seniors who are independent or who require some support. The company operates home health, hospice, and home care agencies, as well as senior living communities throughout Arizona, California, Colorado, Idaho, Montana, Nevada, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, and Wyoming. The Pennant Group, Inc. was incorporated in 2019 and is headquartered in Eagle, Idaho.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​